ONDCP Senior Executive Service Performance Review Board Appointments

Regs.gov: Office of National Drug Control Policy

Published February 28th, 2025

Detected March 14th, 2026

Summary

The Office of National Drug Control Policy (ONDCP) has announced the appointment of four individuals to its Senior Executive Service Performance Review Board. The notice, published on February 28, 2025, identifies the Chair and other members of this board.

View original document View source feed page

What changed

The Office of National Drug Control Policy (ONDCP) has issued a notice announcing the appointment of specific individuals to its Senior Executive Service Performance Review Board. The appointed members include Ms. Martha Gagné as Chair, Ms. Debbie Seguin, Ms. Tilda Farhat, and Ms. Kelly George. This action is taken in accordance with 5 U.S.C. 4314(c)(1).

This is an administrative notice regarding internal government operations. For compliance officers, this notice does not impose any new external obligations or require specific actions. It serves as an informational update on the ONDCP's internal governance structure. No compliance deadlines or penalties are associated with this announcement.

Source document (simplified)

Content

ACTION:

Notice of appointments.

SUMMARY:

The following persons have been appointed to the ONDCP Senior Executive Service Performance Review Board: Ms. Martha Gagné
(as Chair), Ms. Debbie Seguin, Ms. Tilda Farhat, and Ms. Kelly George.

FOR FURTHER INFORMATION CONTACT:

Please direct any questions to Anthony Jones, Acting General Counsel, (202) 881-8862, Office of National Drug Control Policy,
Executive Office of the President, Washington, DC 20503.

Authority: 5 U.S.C. 4314(c)(1).

Dated: February 28, 2025. Anthony Jones, Acting General Counsel. [FR Doc. 2025-03572 Filed 3-5-25; 8:45 am] BILLING CODE 3280-F5-P